MULTIBIC 3 mmol/L potassium, Solution for Haemofiltration Australia - English - Department of Health (Therapeutic Goods Administration)

multibic 3 mmol/l potassium, solution for haemofiltration

fresenius medical care australia pty ltd - calcium chloride dihydrate,glucose monohydrate,magnesium chloride hexahydrate,potassium chloride,sodium bicarbonate,sodium chloride -

MULTIBIC 2 mmol/L potassium, Solution for Haemofiltration Australia - English - Department of Health (Therapeutic Goods Administration)

multibic 2 mmol/l potassium, solution for haemofiltration

fresenius medical care australia pty ltd - calcium chloride dihydrate,glucose monohydrate,magnesium chloride hexahydrate,potassium chloride,sodium bicarbonate,sodium chloride -

SODIUM VALPROATE WOCKHARDT sodium valproate 1000 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 1000 mg/10 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 1000 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

SODIUM VALPROATE WOCKHARDT sodium valproate 400 mg/4 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 400 mg/4 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 400 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

SODIUM CHLORIDE 0.9 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

sodium chloride 0.9 % intravenous infusion bp

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Prismasol 2 mmol/l Potassium solution for haemofiltration and haemodialysis Malta - English - Medicines Authority

prismasol 2 mmol/l potassium solution for haemofiltration and haemodialysis

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate, lactic acid, calcium chloride, dihydrate, potassium chloride, glucose anhydrous - solution for haemofiltration - magnesium chloride hexahydrate 0.102 mmol/l sodium chloride 6.128 mmol/l sodium hydrogen carbonate 2.936 mmol/l lactic acid 0.27 mmol/l calcium chloride dihydrate 0.257 mmol/l potassium chloride 0.149 mmol/l glucose anhydrous 1.1 mmol/l - blood substitutes and perfusion solutions

Prismasol 4 mmol/l Potassium solution for haemofiltration and haemodialysis Malta - English - Medicines Authority

prismasol 4 mmol/l potassium solution for haemofiltration and haemodialysis

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, potassium chloride, glucose anhydrous, lactic acid, magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate - solution for haemofiltration - calcium chloride dihydrate 0.257 mmol/l potassium chloride 0.298 mmol/l glucose anhydrous 1.1 mmol/l lactic acid 0.27 mmol/l magnesium chloride hexahydrate 0.102 mmol/l sodium chloride 6.128 mmol/l sodium hydrogen carbonate 2.936 mmol/l - blood substitutes and perfusion solutions

Physioneal 35 Glucose 2.27% w/v / 22.7 mg/mlSolution for peritoneal dialysis Ireland - English - HPRA (Health Products Regulatory Authority)

physioneal 35 glucose 2.27% w/v / 22.7 mg/mlsolution for peritoneal dialysis

baxter healthcare limited - glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium lactate; sodium bicarbonate - solution for peritoneal dialysis - 2.27 percent weight/volume - hypertonic solutions

Physioneal 35 Glucose 3.86% w/v / 38.6 mg/mlSolution for peritoneal dialysis Ireland - English - HPRA (Health Products Regulatory Authority)

physioneal 35 glucose 3.86% w/v / 38.6 mg/mlsolution for peritoneal dialysis

baxter healthcare limited - glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium lactate; sodium bicarbonate - solution for peritoneal dialysis - 3.86 percent weight/volume - hypertonic solutions

Physioneal 35 Glucose 1.36% w/v / 13.6 mg/mlSolution for peritoneal dialysis Ireland - English - HPRA (Health Products Regulatory Authority)

physioneal 35 glucose 1.36% w/v / 13.6 mg/mlsolution for peritoneal dialysis

baxter healthcare limited - glucose monohydrate; sodium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium lactate; sodium bicarbonate - solution for peritoneal dialysis - 1.36 percent weight/volume - hypertonic solutions